Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens [Experimental Therapeutics]

Lodise, T. P., Bosso, J., Kelly, C., Williams, P. J., Lane, J. R., Huang, D. B.
The American Society for Microbiology (ASM)
Published 2018